Product Information
PAXLOVID 300-100 MG DOSE PACK is a brand product labeled by Pfizer Inc., priced at $49.2339 per EA under NDC 00069504530. Its NADAC has been published 53 times since Aug 20, 2025.
FDA first approved this application on May 25, 2023.
Manufacturer
Pfizer Inc.NDC
00069504530
Classification
Brand
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
New Drug (NDA)
FDA Application
NDA217188FDA Approved
5/25/2023
On Market Since
7/9/2025
Price Statistics
The NADAC for PAXLOVID 300-100 MG DOSE PACK has been published 53 times since Aug 20, 2025, and over the history we have for it it has risen 2.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $49.2339 per EA |
|---|---|
| All-time high | $49.2992 (May 13, 2026) |
| All-time low | $47.8414 (Nov 19, 2025) |
| 52-week high | $49.2992 |
| 52-week low | $47.8414 |
| Median price | $49.2353 |
| Average price | $48.7612 |
| Largest weekly change | +3.0% (Dec 31, 2025) |
| Weeks tracked | 53 |
| Tracking since | Aug 20, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PAXLOVID 300-100 MG DOSE PACK?
The current National Average Drug Acquisition Cost (NADAC) for PAXLOVID 300-100 MG DOSE PACK, manufactured by Pfizer Inc., is $49.2339 per EA (NDC 00069504530), effective Aug 19, 2026.
How has the price of PAXLOVID 300-100 MG DOSE PACK changed over time?
Over the history we have for it, the NADAC for PAXLOVID 300-100 MG DOSE PACK has risen 2.9%. It has been tracked across 53 weekly CMS publications since Aug 20, 2025.
What are the highest and lowest recorded NADAC prices for PAXLOVID 300-100 MG DOSE PACK?
Since Aug 20, 2025, the NADAC for PAXLOVID 300-100 MG DOSE PACK has ranged from a low of $47.8414 (Nov 19, 2025) to a high of $49.2992 (May 13, 2026), with a median of $49.2353 per EA.
Are there cheaper alternatives to PAXLOVID 300-100 MG DOSE PACK?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PAXLOVID 300-100 MG DOSE PACK in a comparable dosage form, but none are currently priced below it.
Who manufactures PAXLOVID 300-100 MG DOSE PACK?
PAXLOVID 300-100 MG DOSE PACK (NDC 00069504530) is labeled by Pfizer Inc., and CMS classifies it as a brand product.